Brief: Interpace Biosciences Q1 Revenue USD 11.515 Million
May 08 (Reuters) - Interpace Biosciences Q1 gross profit USD 7.37 million. Q1 operating expenses USD 5.541 million Q1 operating income USD 1.829 million Q1 net income USD 1.647 million
May 08 (Reuters) - Interpace Biosciences Q1 gross profit USD 7.37 million. Q1 operating expenses USD 5.541 million Q1 operating income USD 1.829 million Q1 net income USD 1.647 million